571 related articles for article (PubMed ID: 28283009)
41. Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.
Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Ouattara A; Takala-Harrison S; Berry AA; Doumbo OK; Plowe CV
PLoS One; 2014; 9(7):e101783. PubMed ID: 24992338
[TBL] [Abstract][Full Text] [Related]
42. Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites.
Marin-Mogollon C; van Pul FJA; Miyazaki S; Imai T; Ramesar J; Salman AM; Winkel BMF; Othman AS; Kroeze H; Chevalley-Maurel S; Reyes-Sandoval A; Roestenberg M; Franke-Fayard B; Janse CJ; Khan SM
Malar J; 2018 Aug; 17(1):288. PubMed ID: 30092798
[TBL] [Abstract][Full Text] [Related]
43. Structural basis of antigenic escape of a malaria vaccine candidate.
Dutta S; Lee SY; Batchelor AH; Lanar DE
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12488-93. PubMed ID: 17636123
[TBL] [Abstract][Full Text] [Related]
44. Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines.
Lu C; Song G; Beale K; Yan J; Garst E; Feng J; Lund E; Catteruccia F; Springer TA
PLoS One; 2020; 15(1):e0216260. PubMed ID: 31967991
[TBL] [Abstract][Full Text] [Related]
45. A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys.
Karen KA; Deal C; Adams RJ; Nielsen C; Ward C; Espinosa DA; Xie J; Zavala F; Ketner G
Infect Immun; 2015 Jan; 83(1):268-75. PubMed ID: 25368113
[TBL] [Abstract][Full Text] [Related]
46. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
47. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.
Ubillos I; Ayestaran A; Nhabomba AJ; Dosoo D; Vidal M; Jiménez A; Jairoce C; Sanz H; Aguilar R; Williams NA; Díez-Padrisa N; Mpina M; Sorgho H; Agnandji ST; Kariuki S; Mordmüller B; Daubenberger C; Asante KP; Owusu-Agyei S; Sacarlal J; Aide P; Aponte JJ; Dutta S; Gyan B; Campo JJ; Valim C; Moncunill G; Dobaño C
BMC Med; 2018 Oct; 16(1):197. PubMed ID: 30376866
[TBL] [Abstract][Full Text] [Related]
48. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
[TBL] [Abstract][Full Text] [Related]
49. Cryo-EM structure of
Oyen D; Torres JL; Cottrell CA; Richter King C; Wilson IA; Ward AB
Sci Adv; 2018 Oct; 4(10):eaau8529. PubMed ID: 30324137
[TBL] [Abstract][Full Text] [Related]
50. Recombinant Mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1/HN strain induces strong immune responses in BALB/c mice.
Zheng C; Xie P; Chen Y
Parasitol Int; 2002 Mar; 51(1):1-7. PubMed ID: 11880222
[TBL] [Abstract][Full Text] [Related]
51. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin.
Leal MT; Camacho AG; Teixeira LH; Bargieri DY; Soares IS; Tararam CA; Rodrigues MM
Clin Vaccine Immunol; 2013 Sep; 20(9):1418-25. PubMed ID: 23863502
[TBL] [Abstract][Full Text] [Related]
52. Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Waitumbi JN; Anyona SB; Hunja CW; Kifude CM; Polhemus ME; Walsh DS; Ockenhouse CF; Heppner DG; Leach A; Lievens M; Ballou WR; Cohen JD; Sutherland CJ
PLoS One; 2009 Nov; 4(11):e7849. PubMed ID: 19924281
[TBL] [Abstract][Full Text] [Related]
53. Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein.
Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Doumbo OK; Takala-Harrison S; Plowe CV
Am J Trop Med Hyg; 2012 May; 86(5):775-81. PubMed ID: 22556073
[TBL] [Abstract][Full Text] [Related]
54. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
PLoS One; 2016; 11(7):e0159449. PubMed ID: 27434123
[TBL] [Abstract][Full Text] [Related]
55. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J
J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829
[TBL] [Abstract][Full Text] [Related]
56. Functional Characterization and Comparison of
Nikolaeva D; Illingworth JJ; Miura K; Alanine DGW; Brian IJ; Li Y; Fyfe AJ; Da DF; Cohuet A; Long CA; Draper SJ; Biswas S
Mol Cell Proteomics; 2020 Jan; 19(1):155-166. PubMed ID: 29089373
[No Abstract] [Full Text] [Related]
57. Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.
Gonzalez C; Hone D; Noriega FR; Tacket CO; Davis JR; Losonsky G; Nataro JP; Hoffman S; Malik A; Nardin E; Sztein MB; Heppner DG; Fouts TR; Isibasi A; Levine MM
J Infect Dis; 1994 Apr; 169(4):927-31. PubMed ID: 8133113
[TBL] [Abstract][Full Text] [Related]
58. Malaria DNA vaccines in Aotus monkeys.
Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
[TBL] [Abstract][Full Text] [Related]
59. Structural ordering of the
Kucharska I; Thai E; Srivastava A; Rubinstein JL; Pomès R; Julien JP
Elife; 2020 Nov; 9():. PubMed ID: 33253113
[TBL] [Abstract][Full Text] [Related]
60. Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.
Kastenmüller K; Espinosa DA; Trager L; Stoyanov C; Salazar AM; Pokalwar S; Singh S; Dutta S; Ockenhouse CF; Zavala F; Seder RA
Infect Immun; 2013 Mar; 81(3):789-800. PubMed ID: 23275094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]